Huma Qamar, M.D., MPH, CMI

Huma Qamar, M.D., MPH, CMI

Chief Medical OfficeratOcugen· In proxies 2024–2025

Pay in FY2025+67% from the year before · Ocugen stock +67.7% the same year

Huma Qamar, M.D., MPH, CMI was paid $2.9M in FY2025 (Dec), up 67%. Ocugen stock rose 67.7% that year.

Pay$100 in the stock at the end of FY23 → $235
Pay is from the Summary Compensation Table of each Ocugen proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. OcugenPublic company · 2 yr
    • Chief Medical Officer2024 – Present · 2 yrStock in role +50%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?